AstraZeneca’s Tagrisso On Course To Indian Debut, Affordability Vow In Tow
Executive Summary
AstraZeneca’s lung cancer treatment appears to have made significant regulatory headway in Asia. Amid its recent record fast approval in China, Tagrisso also appears to have inched closer to potential clearance in India after a key expert panel exempted it from local trial requirements.